Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain

Background: There are no known medicines or vaccines to control the COVID-19 pandemic caused by SARS-CoV-2 (nCoV). Antiviral peptides are superior to conventional drugs and may also be effective against COVID-19. Hence, we investigated the SARS-CoV-2 Spike receptor-binding domain (nCoV-RBD) that int...

Descripción completa

Detalles Bibliográficos
Autores principales: Barh, Debmalya, Tiwari, Sandeep, Silva Andrade, Bruno, Giovanetti, Marta, Almeida Costa, Eduardo, Kumavath, Ranjith, Ghosh, Preetam, Góes-Neto, Aristóteles, Carlos Junior Alcantara, Luiz, Azevedo, Vasco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411520/
https://www.ncbi.nlm.nih.gov/pubmed/32802318
http://dx.doi.org/10.12688/f1000research.24074.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411520/
https://www.ncbi.nlm.nih.gov/pubmed/32802318
http://dx.doi.org/10.12688/f1000research.24074.1

Ejemplares similares